journal article·2025-04

Advancements in NIR-based fluorescence imaging agents for oral oncology: A comprehensive review

Amal Adnan Ashour, Alaa Shafie, Ali Alqarni, Mohammed Fareed Felemban

Dyes and Pigments· Volume 235
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (97)

Show source-provided references
1. Global cancer prevention: an important pathway to global health and development10.1016/j.puhe.2011.09.029 ↗
2. The global burden of women's cancers: a grand challenge in global health10.1016/S0140-6736(16)31392-7 ↗
3. Challenges of cancer control in developing countries: current status and future perspective10.2217/fon.11.101 ↗
4. The epigenomics of cancer10.1016/j.cell.2007.01.029 ↗
5. Review of cancer from perspective of molecular10.1016/j.jcrpr.2017.07.001 ↗
6. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists10.1245/s10434-022-12151-6 ↗
7. Global burden of cancer
8. Physical, psychosocial, relationship, and economic burden of caring for people with cancer: a review10.1200/JOP.2012.000690 ↗
9. Advances in the biology of oral cancer10.1016/j.oraloncology.2006.11.010 ↗
10. Oral cancer: clinical features10.1016/j.oraloncology.2010.03.009 ↗
11. The pathology of oral cancer
12. The pathology of oral cancer10.1080/00310290310001602558 ↗
13. Oral cancer treatment10.1007/s11864-003-0029-4 ↗
14. Genetic etiology of oral cancer10.1016/j.oraloncology.2017.05.004 ↗
15. New insights into oral cancer—risk factors and prevention: a review of literature10.4103/ijpvm.IJPVM_403_18 ↗
16. Oral cancer and precancer: a narrative review on the relevance of early diagnosis10.3390/ijerph17249160 ↗
17. Oral cancer10.4065/82.7.878 ↗
18. The changing epidemiology of oral cancer: definitions, trends, and risk factors
19. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case–control study from India10.1016/j.canep.2017.09.003 ↗
20. Risk factors for squamous cell carcinoma of the oral cavity in young people — a comprehensive literature review10.1016/S1368-8375(00)00135-4 ↗
21. Risk factors for cancer of the mouth: tobacco, betel quid, and
22. Oral cavity cancer in young, non-smoking, and non-drinking patients: a contemporary review10.1016/j.critrevonc.2023.104112 ↗
23. Tobacco use and oral health10.1111/add.15513 ↗
24. Early detection of cancer
25. The future of early cancer detection10.1038/s41591-022-01746-x ↗
26. Early detection of pancreatic cancer, Lancet Gastroenterol
27. Breast cancer early detection: a phased approach to implementation10.1002/cncr.32887 ↗
28. Oral cancer: the importance of early diagnosis and treatment10.2165/00128071-200102040-00005 ↗
29. Advances in oral cancer detection10.1016/bs.acc.2019.03.006 ↗
30. Oral cancer: the importance of early diagnosis and treatment10.2165/00128071-200102040-00005 ↗
31. Challenges in the early diagnosis of oral cancer, evidence gaps and strategies for improvement: a scoping review of systematic reviews10.3390/cancers14194967 ↗
32. Optical fluorescence imaging in oral cancer and potentially malignant disorders: a systematic review10.1111/odi.13071 ↗
33. Illuminating the future of precision cancer surgery with fluorescence imaging and artificial intelligence convergence
34. Activatable fluorescent probes for real-time imaging-guided tumor therapy10.1016/j.addr.2023.114793 ↗
35. Real-time fluorescence imaging in intraoperative decision making for cancer surgery10.1016/S1470-2045(20)30600-8 ↗
36. Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosis10.1002/jev2.12025 ↗
37. Fluorescence sensing and imaging with carbon-based quantum dots for early diagnosis of cancer: a review10.1016/j.jpba.2022.114628 ↗
38. Fluorescence imaging for cancer screening and surveillance10.1007/s11307-017-1050-5 ↗
39. Clinical implications of near-infrared fluorescence imaging in cancer, futur
40. Fluorescence imaging of cancer tissue based on metal-free polymeric nanoparticles – a review10.1039/c3tb20089b ↗
41. Latest developments in molecular tracers for fluorescence image-guided cancer surgery10.1016/S1470-2045(19)30317-1 ↗
42. Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics10.1039/C8CS00234G ↗
43. NIRF nanoprobes for cancer molecular imaging: approaching clinic10.1016/j.molmed.2020.02.003 ↗
44. Enhancing glioblastoma resection with NIR fluorescence imaging: a systematic review10.3390/cancers16233984 ↗
45. Image-guided cancer surgery using near-infrared fluorescence10.1038/nrclinonc.2013.123 ↗
46. Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications10.1021/jacs.0c07022 ↗
47. Fundamentals and developments in fluorescence-guided cancer surgery
48. Recent advances in small-molecule fluorescent probes for diagnosis of cancer cells/tissues10.1016/j.ccr.2022.214946 ↗
49. Progression in near-infrared fluorescence imaging technology for lung cancer management10.3390/bios14100501 ↗
50. Interventional NIR fluorescence imaging of cancer: review on next generation of dye-loaded protein-based nanoparticles for real-time feedback during cancer surgery10.2147/IJN.S295234 ↗
51. Near-infrared fluorescence tumor-targeted imaging in lung cancer: a systematic review10.3390/life12030446 ↗
52. NIR fluorescence imaging and treatment for cancer immunotherapy10.1136/jitc-2022-004936 ↗
53. Recent advances in near-infrared-II fluorescence imaging for deep-tissue molecular analysis and cancer diagnosis10.1002/smll.202202035 ↗
54. Near-infrared fluorophores for biomedical imaging
55. Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment10.1016/j.ccr.2016.04.004 ↗
56. Principles and applications of miniaturized near-infrared (NIR) spectrometers10.1002/chem.202002838 ↗
57. NIR-II light in clinical oncology: opportunities and challenges10.1038/s41571-024-00892-0 ↗
58. Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients10.1097/IGC.0b013e31822b451d ↗
59. Activatable fluorescence probes for “turn-on” and ratiometric biosensing and bioimaging: from NIR-I to NIR-II10.1021/acs.bioconjchem.9b00734 ↗
60. Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers10.1021/cm2028367 ↗
61. Recent advances of optical imaging in the second near-infrared window
62. Recent progress in NIR-II contrast agent for biological imaging10.3389/fbioe.2019.00487 ↗
63. Molecular imaging in the second near-infrared window10.1002/adfm.201900566 ↗
64. Activity-based NIR enzyme fluorescent probes for the diagnosis of tumors and image-guided surgery10.1002/ange.202009796 ↗
65. Noninvasive cancer diagnosis in vivo based on a viscosity-activated near-infrared fluorescent probe10.1021/acs.analchem.0c03803 ↗
66. Near-infrared fluorescent probes for the detection of cancer-associated proteases10.1021/acschembio.1c00223 ↗
67. Recent progress in second near-infrared (NIR-II) fluorescence imaging in cancer
68. Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy10.1039/D2CS00722C ↗
69. Near-infrared fluorescence imaging using organic dye nanoparticles10.1016/j.biomaterials.2014.01.004 ↗
70. A review of NIR dyes in cancer targeting and imaging10.1016/j.biomaterials.2011.06.024 ↗
71. Double sentinel lymph node mapping with indocyanine green and 99m-technetium–tin colloid in oral squamous cell carcinoma10.1016/j.ijom.2015.05.008 ↗
72. Use of indocyanine green near-infrared imaging for sentinel lymph node biopsy in early oral squamous cell carcinoma: a pilot study10.1007/s11307-024-01903-3 ↗
73. Real-time surveillance of surgical margins via ICG-based near-infrared fluorescence imaging in patients with OSCC10.1186/s12957-020-01874-z ↗
74. ανβ3 integrin-targeted ICG-derived probes for imaging-guided surgery and photothermal therapy of oral cancer10.1039/D3AN01761C ↗
75. A real-time near-infrared fluorescence imaging method for the detection of oral cancers in mice using an indocyanine green–labeled podoplanin antibody10.1177/1533033818767936 ↗
76. Clinical application of indocyanine green fluorescence navigation technology to determine the safe margin of advanced oral squamous cell carcinoma10.21037/gs-22-33 ↗
77. Enhancing NIR-II imaging and photothermal therapy for improved oral cancer theranostics by combining TICT and aggregation-induced emission10.1021/acsami.3c14905 ↗
78. A c-MET-targeted topical fluorescent probe cMBP-ICG improves oral squamous cell carcinoma detection in humans10.1245/s10434-022-12532-x ↗
79. In vivo oral sentinel lymph node mapping by near-infrared fluorescent methylene blue in rats10.3390/diagnostics12112574 ↗
80. A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models10.1186/s12951-023-02101-z ↗
81. Application of nanotechnology in biomedicine: a major focus on cancer therapy10.4028/www.scientific.net/JNanoR.35.55 ↗
82. Biomedical applications of nanotechnology10.1007/s12551-016-0246-2 ↗
83. Cancer nanotechnology: application of nanotechnology in cancer therapy10.1016/j.drudis.2010.08.006 ↗
84. Serum protein-based nanoparticles for cancer diagnosis and treatment10.1016/j.jconrel.2020.10.030 ↗
85. Recent advancements in Janus nanoparticle-based biosensing platforms10.1007/s40089-022-00385-x ↗
86. New advances in pre-clinical diagnostic imaging perspectives of functionalized upconversion nanoparticle-based nanomedicine10.1016/j.ccr.2021.213971 ↗
87. Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis10.2147/IJN.S378074 ↗
88. Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field10.2147/IJN.S60206 ↗
89. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice10.2147/IJN.S23348 ↗
90. Bimodal optical diagnostics of oral cancer based on Rose Bengal conjugated gold nanorod platform10.1016/j.biomaterials.2013.02.012 ↗
91. Near-infrared-activated fluorescence resonance energy transfer-based nanocomposite to sense MMP2-overexpressing oral cancer cells10.1021/acsomega.7b01494 ↗
92. A novel multimodal NIR-II nanoprobe for the detection of metastatic lymph nodes and targeting chemo-photothermal therapy in oral squamous cell carcinoma10.7150/thno.30268 ↗
93. Gastrin releasing peptide receptor targeted nano-graphene oxide for near-infrared fluorescence imaging of oral squamous cell carcinoma
94. Peptide functionalized upconversion/NIR II luminescent nanoparticles for targeted imaging and therapy of oral squamous cell carcinoma10.1039/D0BM01737J ↗
95. NIR-II emissive dye based polymer nanoparticle targeting EGFR for oral cancer theranostics10.1007/s12274-022-4239-0 ↗
96. A novel second near-infrared theranostic agent: a win–win strategy of tracing and blocking tumor-associated vessels for oral squamous cell carcinoma, Mater
97. Near-infrared-II Ag2S quantum dot probes targeting podoplanin enhance immunotherapy in oral squamous cell carcinoma10.1016/j.biopha.2023.116011 ↗